Interestingly, conventional Th2 biomarkers (IL-4, IL-5, IL-13, IgE, TARC, and TSLP) showed no significant differences between asthma and control subjects in our study cohort, suggesting that these markers alone may not sufficiently stratify pediatric asthma phenotypes. This evidence concerns the gene TSLP and asthma.